Adenoma hipofisiario en una paciente embarazada, evolución y manejo: Reporte de caso y revisión de la literatura
PDF
HTML

Palabras clave

embarazo
análogos de somatostatina
adenoma hipofisiario
pregnancy
somatostatin analogues
pituitary adenoma

Cómo citar

Mejía López, M. G., Filizzola Montero, V. C., Tovar Cortés, H., & Rojas, W. (2017). Adenoma hipofisiario en una paciente embarazada, evolución y manejo: Reporte de caso y revisión de la literatura. Revista Colombiana De Endocrinología, Diabetes &Amp; Metabolismo, 2(1), 54–57. https://doi.org/10.53853/encr.2.1.73

Resumen

Se reporta el caso de una paciente de 32 años quien consulta al servicio de endocrinología por crecimiento acral, hiperhidrosis, amenorrea, cefalea y cambios faciales. Se encuentra test de hormona de crecimiento postsupresión con 100 g de glucosa positivo e imagen de resonancia magnética nuclear con macroadenoma hipofisiario con quiasma libre. Se ordena resección de la masa e inicio de análogo de somatostatina; sin embargo, la paciente no inicia la medicación, además hay pérdida en el seguimiento clínico. Tiempo después consulta de nuevo al servicio de endocrinología en estado de embarazo. Se decide mantener en observación clínica durante la gestación, sin evidenciarse complicaciones secundarias a su patología ni en la madre ni en el neonato. Presentamos aquí la secuencia de hechos con sus resultados y una revisión de la literatura.

Abstract
This is the case of a 32-year-old female who was seen at the Endocrinology service complaining of acral growth, hyperhidrosis, amenorrhea, headache and facial changes. The post-suppression growth hormone test with 100 g of glucose was positive and her MRI showed a pituitary macroadenoma without chiasm compression. Resection of the mass was scheduled followed by the use of a somatostatin analogue. However, the patient did not initiate the medication, and was lost for follow-up. Later on she visited again the Endocrinology Service while pregnant. It was decided to keep her under clinical observation during her pregnancy, with no evidence of complications secondary to the condition neither for the mother nor for the newborn. We report here the sequence of events with their results and a review of the literature.

https://doi.org/10.53853/encr.2.1.73
PDF
HTML

Citas

1. Asa SL, Ezzat S: The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev 19 (6): 798-827, 1998.
2. Ezzat S, Asa SL, Couldwell WT, et al.: The prevalence of pituitary adenomas: a systematic review. Cancer 101 (3): 613-9, 2004.
3. Kovacs K, Horvath E, Vidal S: Classification of pituitary adenomas. J Neurooncol 54 (2): 121-7, 2001.
4. Scheithauer BW, Kovacs KT, Laws ER Jr, et al.: Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 65 (6): 733-44, 1986.
5. Pernicone PJ, Scheithauer BW, Sebo TJ, et al.: Pituitary carcinoma: a clinico- pathologic study of 15 cases. Cancer 79 (4): 804-12, 1997.
6. Ragel BT, Couldwell WT: Pituitary carcinoma: a review of the literature. Neurosurg Focus 16 (4): E7, 2004.
7. Karaca Zuleyha, MD, Fahrettin Kelestimur. Pregnancy and other pituitary disorders(including GH deficiency) Best Practice & Research Clinical Endocrinology & Metabolism 25 (2011) 897–910.
8. Karaca, Z. F Tanriverdi, K Unluhizarci and F Kelestimur. Pregnancy and pituitary disorders. European Journal of Endocrinology (2010) 162 453–475.
9. Motivala et al. Endocrinol Metab Clin N Am 40 (2011) 827–836.
10. Maiter, Dominique, Primeau, Vanessa. 2012 Update in the treatment of prolactinomas. Annales d’Endocrinologie 73 (2012) 90–98.
11. Melded S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA; Endocrine Society. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011 Feb;96(2):273-88.
12. Gillam MP, Molitch ME, Lombardi G, Colao A. Advances in the treatment of prolactinomas. E ndocr Rev. 27:485–534, 2006.
13. Molitch M.E. Prolactinoma in pregnancy Best Practice & Research Clinical Endocrinology & Metabolism 25 (2011) 885–896.
14. Konopka P, Raymond JP, Merceron RE, Seneze J. Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas. Am J Obstet Gynecol 146:935–938. 1983.
15. Jai Bhagwan Sharma, Kallol K. Roy, Pushparaj Mohanraj, Sunesh Kumar, De- bjyoti Karmakar, Jinee Barua.
16. Bronstein, M. D. et al. Management of pituitary tumors in pregnancy. Nat. Rev. Endocrinol. 7, 301–310 (2011).
17. Cheng V., et al: Pregnancy and acromegaly: a review. Pituitary. 2012 Mar;15(1):59-63.
18. Katznelson, Laurence, L, John. D. Atkinson. Cook, David M. Shereen Z. Ezzat, Amir H. Hamrahian,. Miller Karen K. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice. Endocrine Practice Vol.17 (suppl 4) Jul/ago 2011.
19. Dias Monike, Boguszewski,Cesar. Gadelha, Monica. Kasuzi, Leandro. Musolino,Nina. Vieira, J. and Abucham ,J. Acromegaly and pregnancy: a prospective study. European Journal of Endocrinology.
20. Caron Ph, et al: Acromegaly and pregnancy: a retrospective multicenter study of 59 pregnancies in 46 women. A JCEM 2010; 95:4680-87.
21. Cheng Sonia, Grasso Ludovica, Jose A. Martinez-Orozco, Rany Al-Agha, Pivonello Rosario, Colao Ana Maria and Ezzat Shereen. Pregnancy in acromegaly: experience from two referral centers and systematic review of the literatura. Clinical Endocrinology (2012) 76, 264–271.
22. Fleseriu M, m.d, et al: Acromegaly: a review of current medical therapy and new drugs on the horizon. Neurosurg Focus 29 (4):E15, 2010.
23. Riddle Brian, Susan. Bidlingmaier,Martin.P, Michael . Wajnrajch, Stuart A. Weinzimer, and Inzucchi, Silvio. Treatment of Acromegaly with Pegvisomant during Pregnancy: Maternal and Fetal Effects. The Journal of Clinical Endocrinology & Metabolism . (2007)92(9):3374–3377.
24. Valassi Elena. Acromegaly and pregnancy. Endocrinol Nutr. 2013;60(1):1-3.
25. Van der Lely AJ1, Gomez R, Heissler JF, Åkerblad AC, Jönsson P, Camacho- Hübner C, Ko?towska-Häggström M. Pregnancy in acromegaly patients treated with pegvisomant. Endocrine. 2014 Dec 27.
26. Bronstein M, et al: Medical management of pituitary adenomas; the special case of management of the pregnant woman. Pituitary. 2002;5:99-107.
27. Dreyfus M, Lehmann M, Schlienger JL. Patología endocrina y embarazo Enciclopedia médicoquirúrgica Madrid: Elsevier. 2003; tomo 4:5048-C-10.
28. López S et al. Síndrome de Cushing en el embarazo. Prog Obstet Ginecol. 2006;49(4):205-9.
29. Nieman, Lynnette K. M, Beverly . Biller. Newell-Price, Jonh. Savage, Martin. Stewart, Paul. And. Montori, Victor M. The medical management of Cushing’s syndrome during pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology 168 (2013) 1–6.
30. Wei How Lim, David J. Torpy, William S. Jeffries. The medical management of Cushing’s syndrome during pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology 168 (2013) 1–6.
Los autores deben declarar revisión, validación y aprobación para publicación del manuscrito, además de la cesión de los derechos de publicación, mediante un documento que debe ser enviado antes de la aparición del escrito.  Puede consultar una copia del documento aquí

Descargas

Los datos de descargas todavía no están disponibles.